RECURSION PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition.

On August 9, 2022, Recursion Pharmaceuticals, Inc. issued a press release announcing its results of operations and financial condition for the second quarter June 30, 2022. A copy of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

On August 9, 2022, Recursion Pharmaceuticals, Inc. released an updated investor presentation. The investor presentation will be used from time to time in meetings with investors. A copy of the presentation is attached hereto as Exhibit 99.2.

The information furnished pursuant to Item 2.02 (including Exhibit 99.1) and 7.01 (including Exhibit 99.2) on this Form 8-K, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number              Description
                              Press release issued by Recursion Pharmaceuticals, Inc. dated
99.1                            August     9    , 2022
                              Investor presentation of Recursion Pharmaceuticals, Inc. dated August
99.2                        9, 2022
                            Cover Page Interactive Data File (embedded within the Inline XBRL
104                         document)

© Edgar Online, source Glimpses